Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
IPSC
Century Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
IPSC
Century Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
AMGN
with
IPSC
No shared trading history for AMGN and IPSC.
Shared co-movers: not yet measured (IPSC).
AMGN, solid
IPSC, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
AMGN
Amgen Inc
Change
461.49
▼
−3.55%
· post 460.22
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
IPSC
Century Therapeutics, Inc.
Change
1.50
▼
−9.89%
· post 1.50
Closed
Nov 5 '26
Mkt cap
$273.4M
Revenue
$109M
Q1 FY25
Revenue
$7M
FY24
vs
Compare
Closed
Nov 5 '26
AMGN
Amgen Inc
vs
IPSC
Century Therapeutics, Inc.
461.49
▼
−3.55%
post 460.22
Price
1.50
▼
−9.89%
post 1.50
$249.0B
Mkt cap
$273.4M
Q3 FY26
$10.4B
Revenue
$109M
Q1 FY25
FY25
$36.8B
Revenue
$7M
FY24
Change
Change
AMGN
461.49
▼
−3.55%
vs
IPSC
1.50
▼
−9.89%
Closed
Nov 5 '26